severe disease in humans until the recent outbreaks, when it was linked to 26 microcephaly in newborns in Brazil and to Guillain--Barré Syndrome in adults in 27
2
Zika virus (ZIKV) is an arthropod--borne enveloped virus belonging to the flavivirus 38 genus in the family Flaviviridae, which also includes the human pathogenic yellow fever, 39 dengue, West Nile and tick--borne encephalitis viruses 1 . Flaviviruses have two structural 40 glycoproteins, prM and E (for precursor Membrane and Envelope proteins, 41 respectively), which form a heterodimer in the endoplasmic reticulum (ER) of the 42 infected cell and drive the budding of spiky immature virions into the ER lumen. These 43 particles transit through the cellular secretory pathway, during which the trans--Golgi 44 protease, furin, cleaves prM. This processing, required for infectivity, results in loss of a 45 large fragment of prM and reorganization of E on the virion surface. The mature 46
particles have a smooth aspect, with 90 E dimers organized with icosahedral symmetry 47 in a "herringbone" pattern 2,3 . 48
Three--dimensional cryo--EM structures of the mature ZIKV particles have recently been 49 reported to near atomic resolution (3.8 Å) 4, 5 , showing that it has essentially the same 50 organization as the other flaviviruses of known structure, such as dengue virus (DENV) 51 3 and West Nile virus 6, 7 . The E protein is about 500 amino acids long, with the 400 N--52
terminal residues forming the ectodomain essentially folded as β--sheets with three 53 domains named I, II and III, aligned in a row with domain I at the center. The conserved 54 fusion loop is at the distal end of the rod in domain II, buried at the E dimer interface. At 55 the C--terminus, the E ectodomain is followed by the so--called "stem", featuring two α--56 helices lying flat on the viral membrane (the "stem" helices), which link to two C--57
terminal trans--membrane α--helices. The main distinguishing feature of the ZIKV virion 58
is an insertion within a glycosylated loop of E (the "150" loop), which protrudes from 59 the mature virion surface 4,5 . 60
Flaviviruses have been grouped into serocomplexes based on cross--neutralization 61 studies with polyclonal immune sera 8 . The E protein is the main target of neutralizing 62 antibodies, and is also the viral fusogen; cleavage of prM allows E to respond to the 63 endosomal pH by undergoing a large--scale conformational change that catalyzes 64 membrane fusion and releases the viral genome into the cyotosol. Loss of the precursor 65 fragment of prM lets the E protein fluctuate from its tight packing at the surface of the 66 virion, transiently exposing otherwise buried surfaces. One surface exposed by this 67 "breathing" is the fusion--loop epitope (FLE), which is a dominant cross--reactive 68 antigenic site 9 . Although antibodies to this site can protect by complement--mediated 69 mechanisms, as shown for West Nile virus in a mouse model 10 , they are poorly 70 neutralizing and lead to antibody--dependent enhancement (ADE) 11--15 thereby 71
aggravating flavivirus pathogenesis and complicating the development of safe and 72 effective vaccines. 73 3
We recently reported the isolation and structural characterization of a panel of 74 antibodies isolated from dengue patients 13, 16 . Most of these antibodies target the FLE, 75 but others target a quaternary site readily accessible at the exposed surface of the E 76 protein on the virion, at the interface between the two E subunits in the dimer. These 77 broadly neutralizing antibodies (bnAbs), termed EDE for "E--dimer epitope", potently 78 neutralize all four serotypes of DENV. Their binding site is conserved across serotypes 79 because it is also the interaction site of prM with E dimers during transport of the 80 immature virus particles through the Golgi apparatus of the cell. There were two 81 subsets of EDE Mabs, characterized by a differential requirement for glycosylation on 82 the 150 loop for binding. The EDE1 bnAbs bind better in the absence of glycan, whereas 83 EDE2 bnAbs bind better when the glycan is present. 84
In this study we show that the EDE Mabs neutralize ZIKV as potently as they neutralize 85 DENV. We also find that the FLE antibodies, which neutralize DENV --although not as 86 potently as the EDE Mabs -- do not neutralize ZIKV at concentrations up to 1μM in spite 87 of a high affinity for the recombinant ZIKV E protein. We further describe the crystal 88 structures of the ZIKV E protein dimer alone and in complex with EDE1 C8 and EDE2 89 A11, identifying their binding determinants. 90
A ZIKV--DENV super serogroup 91
Phylogenetic analyses of the main human pathogenic flaviviruses using the amino acid 92 sequences of the viral RNA polymerase NS5 indicate a clustering of ZIKV with the group 93 of mosquito--borne encephalitic viruses (Fig. 1a) . The clustering is different when the 94 amino acid sequences of the E protein are considered, with ZIKV branching with the 95 DENV group. If the sequence clustering extends to the antigenic surface of E, antibodies 96 that cross--react with several DENV serotypes should also bind ZIKV E. To test this 97 hypothesis we used bio--layer interferometry (BLI) to study the binding properties of a 98 poorly neutralizing, cross--reactive FLE antibody and the potently neutralizing EDE 99 mAbs for recombinant, soluble ZIKV E ectodomain (ZIKV sE) produced in insect cells 100 (see Online methods). The FLE mAb (P6B10) bound nearly 10fold more tightly than did 101 EDE1 C8 (apparent Kd 1.5 nM vs. 9 nM) and nearly 1000 times more tightly than EDE2 102 A11 ( Fig. 1b and ED Fig. 1a ). Consistent with their affinities, we could isolate a complex 103 of ZIKV sE with a C8 Fab by SEC, but not with an A11 Fab (ED Fig. 1b ). 104
Neutralization assays in African green monkey (VERO) cells using these and other 105 members of the three antibody subsets, showed that the EDE1 antibodies strongly 106 neutralize ZIKV, whereas the EDE2 were at least one log less potent. In spite of its 107 strong affinity, P6B10 did not neutralize in the concentration range used, nor did any of 108
the two other FLE antibodies tested (Fig. 2) . The EDE1 bnAbs neutralized better the 109
African strain HD78788, which has over the years been cell--culture adapted and 110 4 passaged in suckling mice brain, and lacks E glycosylation. The IC50 against the PF13 111 strain, isolated in French Polynesia in 2013 and in which the E protein is glycosylated at 112 position 154, was in the nanomolar range and comparable to --or lower than -that 113 against the four serotypes of DENV (Table 1) . The EDE2 bnAbs showed no difference in 114 neutralization of the two strains, suggesting that the presence of the N154 glycan in the 115 ZIKV E protein did not enhance the interaction. 116
The ZIKV / EDE bnAbs immune complexes 117
We crystallized unliganded ZIKV sE and complexes of ZIKV sE with EDE1 C8 and EDE2 118 A11 with scFv and Fab fragments, respectively (ED Table1). In the structure of 119 unliganded ZIKV sE, the 150 loop is ordered, unlike the unglycosylated 150 loop in the 120 recently determined structure of the protein produced in bacteria and refolded in 121 vitro 17 . In contrast to our insect--cell secreted protein, which is a dimer (ED Fig.  1b ) the 122 refolded protein was reported to be monomeric in solution, suggesting that the glycan 123 may help structure the loop and promote sE dimerization. 124
The antibodies recognize a quaternary epitope in the ZIKV sE dimer in the same way 125 they recognize the DENV serotype 2 (DENV--2) sE dimer described earlier 16 . The amino--126 acid residues participating in the contacts, for both the ZIKV and DENV--2 structures, are 127
shown in ED Fig. 2 . The pattern is, as expected, very similar, with the few differences 128 highlighted in red frames in ED Fig.  2b . Both epitopes in the sE dimer are occupied in 129 the case of the complex with C8 ( Fig. 3a) whereas only one is occupied in the case of 130 A11 (Fig. 4a ). Inspection of the crystal environment showed that a second Fab could not 131 be docked at this position without clashing with neighboring complexes in the crystal. 132
This observation indicates that crystal growth selected for incorporation of sE dimers 133 with a single Fab bound, which is facilitated by the low affinity of A11. 134
The bnAbs dock on ZIKV sE at different angles than they do on DENV--2 sE (see insets in 135
Figs. 3a and 4a). In the case of the C8 complex, the difference in docking results mainly 136 from an altered curvature of the sE dimer. We note that the conformation of ZIKV sE in 137 complex with the antibodies is very similar to the one it adopts on the virus particle, 138 with roughly 1.5 Å root mean square deviation (RMSD) for 790 Cα atoms (see ED Table  139 2). The unbound ZIKV sE crystallized here displays a more distant conformation (2.5 Å 140
RMSD when comparing to both virion ZIKV E and either of the sE antibody complexes), 141
suggesting that the antibodies stabilize a conformation close to that on the viral particle. 142
In contrast, the same comparisons done for DENV--2 sE, alone or in complex with the 143 bnAbs result in RMSD values of 5--7 Å with respect to the E conformation on the DENV 144 virion observed by cryo--EM 3 . For comparison, superposition of the ectodomain of virion 145 E from ZIKV 5 and DENV--2 3 results in a similar 1.5 Å RMSD, indicating that they are 146 presented roughly in the same way, but that DENV sE is more deformable in solution. 147 5
This malleability may reflect the conformational breathing reported for DENV E 18 . 148
Instead, ZIKV sE remains in a similar conformation in the absence of the interactions 149 with the underlying stem α--helices and with the M protein (the membrane--anchored 150 remnant of prM after furin cleavage) on the virion, in line with the higher stability of the 151 ZIKV particles described recently 4 . 152
EDE1 C8 complex 153
The total buried surface area of EDE1 in the complex with ZIKV sE is about 900 Å 2 , 154 compared to about 1300 Å 2 in the DENV--2 sE complex (ED Table  3 ). Fig.  3d shows the 155 conservation of the epitope, and Figs. 3e and 3f compare the C8 footprint on ZIKV and 156 DENV--2 sE. The DENV--specific glycan at position N67, which is ordered in the DENV--2 157 sE structure ( Fig. 3c ), accounts for around two--thirds of the overall difference in 158 footprint area. The N67 glycan interacts with the framework region 2 of the heavy chain 159 (FRH2), and its absence in ZIKV sE shows that these contacts are not essential for 160
binding. The key cluster of interactions that is maintained is centered on β--strand b of 161 domain II, with side chains from CDRs H2, H3 and L3 recognizing all the available 162 hydrogen bond donors (NH atoms) and acceptors (main chain carbonyls) of the bdc β--163 sheet edge ( Figs. 3b and 3c ). In addition, the fusion loop main chain (which contains 164 several glycine residues) and the disulfide bond between Cys74 and Cys105, are framed 165 by aromatic side chains of the CDRs L1 and L3 (see also ED Figure 3 ). Residues from 166 these two CDRs also recognize strictly conserved side chains of the fusion loop (Arg 99) 167 or nearby (Gln 77). 168
Across the dimer interface, and as in the complex with DENV--2, the 150 loop is partially 169 disordered, with no detectable density for the N154 glycan ( Fig.  3a and ED Fig.  3d ). As 170
shown in ED Fig. 3 , the interacting residues across the dimer interface are different, 171
reflecting the more limited sequence conservation in these regions of the E protein: in 172 the DENV--2 sE complex, these contacts are with β--strands A and B of domain III, but in 173 ZIKV they mainly involve Lys 373 from β--strand E interacting with CDRs L1 and L2, 174
with a network of direct or water--mediated hydrogen bonds (ED Figs. 3b and 3c ). 175
Similarly, a number of charged residues in domain I and from the nearby kl loop of 176 domain II across the interface, contribute to the binding and interact with the heavy 177 chain CDRs H2 and H3 (ED Figs.  3e  and  3f ). All the polar interactions between C8 and 178 ZIKV sE are listed in ED Tables 4 and 5, and the electrostatic surface of the epitope is 179 displayed in ED Fig. 4 , left panel. In summary, these observations identify the conserved 180 cluster of contacts with the b strand and the fusion loop in domain II as the main 181 binding determinants of C8, with additional contacts from across the dimer interface --182 or from the N67 glycan in DENV --further stabilizing but not determining the 183 interaction. 184 6 EDE2 A11 complex 185 ED Figure 4 compares the footprint of C8 and A11 on ZIKV sE, together with the surface 186 electrostatic potential of the complexes, which shows a strong basic patch on sE in the 187 C8 complex due to the disorder of the 150 loop. As shown in ED Fig.  5 , C8 would clash 188 with the glycan had the loop remained in place, as was the case in the complex with 189 DENV--2 sE 16 . In the A11 complex the 150 loop remains in the same conformation as in 190
the cryo--EM structures of the virion (ED Fig. 5a ) and in the X--ray structure of 191 glycosylated unliganded sE reported here. In the DENV--2 sE / A11 complex, the glycan 192 is recognized by an α--helix in the long CDR3 loop (Fig.  4e) . The difference in length in 193 the 150 loop of E in ZIKV compared to DENV shifts the glycan position by about 6-- 7Å, 194 such that it cannot make the same interactions with the CDR H3 α--helix (Figs. 4d and e 195 and ED Fig.  5b ). As a consequence, the A11 antibody docks at a different angle on ZIKV 196 sE than it does on DENV--2 sE, even accounting for the difference in sE dimer curvature 197 ( Fig. 4a , inset). The contacts along the b--strand are preserved ( Fig. 4b and c ). Compared 198 to C8, the b strand is recognized only at its end (residues 71 and 73), whereas C8 199 recognizes it all along, from residue 68 (or from 67 in DENV). 200
DISCUSSION

201
Our results identify the structural details of a quaternary epitope that provides a 202 previously unrecognized link of potent cross--neutralization between Zika and dengue 203 viruses, and thus identifies an antigenic flavivirus cluster beyond the traditional 204 serocomplexes. This relationship defines a super serogroup on the basis of strong cross--205 neutralization through a conserved epitope that had not been recognized using 206 polyclonal sera 8 . This finding thus introduces the possibility of developing a universal 207 vaccine protecting against all the viruses from this group. 208
Vaccine design against dengue virus has been hampered by the heterogeneity of DENV 209 particles and the need to use polyvalent formulas to immunize against all four serotypes 210 19, 20 . One feature of DENV is that it undergoes incomplete furin maturation cleavage of 211 prM in many cell types, giving rise to heterogeneous mosaic particles with an immature--212 like spiky patch on one side and a smooth mature--like region on the opposite side 21 . 213
These particles are infectious, as they can fuse with the cellular membrane through the 214 smooth, mature side. Because the FLE is exposed in immature regions 22 , most of the 215 antibody response in DENV infected patients is directed against it 23 . These cross--216 reactive antibodies coat the particles on the "immature side" 22 but neutralize only 217 weakly, because they can bind the "mature side" only when the E protein "breathes" 24--218 26 . A recently published structure of monomeric ZIKV sE in complex with an FLE--219 specific monoclonal murine antibody of low neutralizing activity indeed shows that its 220 binding site would be occluded in the dimeric E protein on mature infectious virions 17 . 221 7
The observation that P6B10 and other FLE antibodies still neutralize DENV 13 suggests 222 that E in the mature patches on DENV spends more time in conformations that expose 223 the FLE than does E in those patches on ZIKV. This inference is consistent with the high 224 thermal stability of ZIKV reported recently 4 . 225
Our results suggest that the epitope targeted by the EDE1 bnAbs is better suited for 226
developing an epitope--focused vaccine for viruses in the ZIKV/DENV super--serogroup 227 than is the FLE, which induces poorly neutralizing and strongly infection--enhancing 228
antibodies 12--14 . The EDE1 is also better suited than the related EDE2 epitope: although 229 the EDE1 Mabs require an E dimer to bind, the actual binding determinants are 230 centered on the b strand and on the highly conserved, E--dimer--exposed elements of the 231 fusion loop, as shown by the comparison between their binding to DENV--2 and ZIKV sE. 232
The fact that EDE2 bnAbs rely heavily in their contact points on the adjacent subunit --233 on the variable 150 loop in which glycosylation is not always present --is a drawback, as 234 demonstrated by their poor affinity ( Fig. 1 ) and by their strong induction of ADE 12 . 235
Targeting the b strand and the E--dimer exposed elements of the fusion loop appears as 236 a powerful alternative to the multi--immunogen approaches against the DENV cluster 237 that have had limited success in clinical trials 27 . As the E protein polypeptide chain 238 displays neither insertions nor deletions in the region of the b strand for any medically 239 relevant flavivirus, this region presents a low risk of inducing escape mutations, most 240 likely because it is also the interacting site with prM during virus maturation. Finally, in 241 a more immediate application, our study also suggests that the EDE1 antibodies -242 perhaps carrying the "LALA" mutation 28 if effector functions are to be avoided -- could 243 be useful for immune prophylaxis for pregnant women at risk of contracting ZIKV 244 infection. respect to the antibody (the antibody is exactly in the same orientation in both panels) 405
d,e) Zoom of the glycan on the 150 loop for ZIKV sE (d) and for DENV--2 sE (e), with 406
sugar residue numbers described in the key. The CDR H3 helix is too far to make 407
interactions with the glycan, as is the case in the DENV--2 structure (see ED Figs 2b and 408 5b). 409
METHODS 410
Recombinant production of ZIKV sE protein. Recombinant Zika virus sE protein 411
(strain H/PF/2013, GenBank accession no. KJ776791) was produced with a tandem 412 strep--tag in the Drosophila Expression System (Invitrogen) as described previously 29, 30 . 413
A chemically synthesized DNA fragment (GeneArt) containing the Zika sE sequence 414
(amino acid 1--408) was cloned into the expression vector pT389 31 that encodes the 415 export signal sequence BIP, an enterokinase cleavage site and the strep--tag. Drosophila 416
Schneider 2 cells were stably transfected using blasticidin for selection. Protein 417 expression was induced by the addition of CuSO4 and supernatants were harvested 7--10 418 days after induction. Antigens were purified via affinity chromatography with 419
Streptactin columns (IBA) according to the manufacturer's instructions. A final 420 purification gel filtration step used a Superdex increase 200 10/300 GL column 421 equilibrated in 50 mM Tris pH8, 500 mM NaCl. 422
Production of antigen--binding (Fab) and single--chain Fv (scFv) fragments of the 423 bnAbs. The bnAb fragments were cloned into plasmids for expression as Fab 32 and 424 scFv 33 in Drosophila S2 cells. The constructs contain a tandem strep tag fused at the C--425 terminus (only of the heavy chain in the case of the Fab) for affinity purification. The 426 purification protocol included a Streptactin affinity column followed by gel filtration as 427 described above. 428
Expression of human monoclonal anti--DENV E antibodies. Full IgG antibodies were 429 produced in 293T cells after co--transfection of plasmids containing heavy and light 430 chains of immunoglobulin G1 as described in ref. 13 . 431 13
Immune complex formation and isolation. The purified ZIKV sE protein was mixed 432
with Fab A11 or scFv C8 (in approximately twofold molar excess) in standard buffer 433 (500 mM NaCl, Tris 50 mM pH 8.0). The volume was brought to 0.5 ml by centrifugation 434 in a Vivaspin 10 kDa cutoff; after 30 min incubation at 4°C, the complex was separated 435 from excess Fab or scFv by size--exclusion chromatography (SEC) for ZIKV sE and scFv 436
C8. For ZIKV sE and Fab A11 no apparent complex formation could be seen in SEC; 437 therefore a solution containing sE at a concentration of 1.5 mg/ml and Fab A11 at a 438 concentration of 3 mg/ml (corresponding to a molar ratio ~ 1:2 antigen:antibody) was 439 directly used for crystallization. In all cases, the buffer was exchanged to 150 mM NaCl, 440 15 mM Tris, pH 8 for crystallization trials. The protein concentrations used for 441 crystallization, determined by measuring the absorbance at 280 nm and using an 442 extinction coefficient estimated from the amino--acid sequences, are listed in Extended 443
Data formed was then monitored for 10 min by dipping sensors in assay buffer alone. 458
Operating temperature was maintained at 25 °C. The real--time data was analyzed using 459 Scrubber 2.0 (Biologic Software) and Biaevaluation 4.1 (GE Healthcare). Specific signals 460
were obtained by double--referencing, ie subtracting non--specific signals measured on 461 non--specific IgG--loaded sensors and buffer signals on specific IgG--loaded sensors. 462
Association and dissociation profiles, as well as steady--state signal vs concentration 463 curves, were fitted assuming a 1 :1 binding model. 464
Crystallization and X--ray structure determinations. The crystallization and cryo--465
cooling conditions for diffraction data collection are listed in Extended Data Switzerland). The crystals having the less anisotropic diffraction data were used to 475 solve the structures. The datasets were indexed, integrated, scaled and merged using 476 XDS 34 and AIMLESS 35 . A preliminary model of ZIKV sE protein was built from the DENV--477 2 sE (4UTA) structure using the structure homology--modeling server SWISS--MODEL 36 . 478
The structures of the complexes were then determined by molecular replacement with 479 PHASER 37 using the search models listed in Extended Data Table 1. AIMLESS and  480 PHASER programs were used within the CCP4 suite 38 . 481
The DEBYE and STARANISO programs developed by Global Phasing Ltd. were applied 482 to the AIMLESS scaled data without truncation of the resolution, using the STARANISO 483 server (http://staraniso.globalphasing.org/). These softwares perform an anisotropic 484 cut--off of merged intensity data with a Bayesian estimation of the structure amplitudes, 485
and apply an anisotropic correction to the data. These corrected anisotropic amplitudes 486
were then used for further refinement of both structures with BUSTER/TNT 39 . Please 487 note that the Extended Data Table  1 shows the refinement statistics for the full sets of 488 reflections truncated at the best high--resolution along h, k or l axis, values given by 489 AIMLESS before the anisotropic corrections computed by STARANISO software. 490
The models were then alternatively manually corrected and completed using COOT 40 491 and refined using BUSTER/TNT against the amplitudes corrected for anisotropy. 492
Refinements were constrained using non--crystallographic symmetry. consortium. Viral stocks were prepared from supernatant of infected C6/36 cells (ATCC 521 CRL--1660) clarified by centrifugation at 3000 g at 4°C and titrated on Vero cells (ATCC 522 CRL--1586) by a focus--forming assay. Stocks were kept at --80°C until use. All cell lines 523
were free from mycoplasma contamination. 524 Neutralization Assays. Virus neutralization by the tested human antibodies was 525 evaluated using a focus reduction neutralization test (FRNT). About 100 ffu (focus 526 forming unit) from virus stocks were incubated with a serial dilution of antibody for 1h 527 at 37°C. The mixture was then added to Vero cells and foci were let to develop in 528 presence of 1.5% methylcellulose for two days. Foci were then stained after fixation 529 with 4% formaldehyde using anti--E 4G2 antibody (ATCC HB--112) and anti--mouse HRP--530 conjugated secondary antibody (ThermoFisher 31430). The foci were visualized by 531 diaminobenzidine (DAB) (Sigma D5905) staining and plates were counted using the 532
ImmunoSpot S6 red background highlights identical residues. Secondary structure elements are 601 indicated together with their labels above (ZIKV) and below (DENV--2) the sequences. 602
The domain organization of ZIKV and DENV--2 sE is symbolized by a colored bar above 603 the sequences (domain I red, domain II yellow, domain III blue and the fusion loop 604 orange). Residues involved in polar and van der Waals protein--protein contacts are 605 marked using blue and green symbols, respectively, as indicated in the inset key, 606 displayed above and below the alignment for ZIKV and DENV--2 sE, respectively. Full 607 and empty symbols correspond to antibody contacts on the reference subunit of sE 608
(defined as the one contributing the fusion loop to the epitope) and the opposite 609 subunit of sE, respectively. Residues contacted only by the heavy or light chain are 610 marked with squares or triangles, respectively, and those contacted by both antibody 611 chains with circles. The details of the amino acid contacts are listed in the ED Tables 4 612 and 5. Dots above the sequences mark every 10 residues on the ZIKV sE sequence. 613
Disulfide bridges are numbered in green above the sequences. mutations are in red and residues arising from recombination at the V--D--J junction are 619 in green. Symbols above and below the sequences mark residues involved in contacts 620
with ZIKV and DENV--2 sE, respectively, coded for the contacted site in sE as indicated in 621
the key (inset at the bottom). Polar and van der Waals contacts are shown in blue and 622 green, respectively. The antibody residues contacting the reference sE subunit (defined 623 as the one contributing the fusion loop to the epitope) are marked by plain color 624 symbols while those making contact across the dimer interface by empty colored 625 symbols. Red boxes highlight the contacts found in the DENV--2 sE complex and absent 626 in the ZIKV sE complex, involving N67 glycan, kl and 150 loops. The details of the polar 627 contacts are listed in the Extended Data Tables 4 and 5 (see also Figs 3e and 3f). The  628 predicted vH and vL germline alleles are indicated with the corresponding CDR lengths 629 (see Table 1 063 (±0.016)  0.013 (±0.025)  0.54 (±0.04) 0.18 (±0.02) 1.89 (±0.79) 0.08 (±0.03)  752--2 B2  EDE1  1.062 (±0.362)  0.021 (±0.004)  0.32 (±0.05) 0.23 (±0.02) 0.22 (±0.09) 0.44 (±0.14)  747(4) A11  EDE2  0.904 (±0.191)  0.506 (±0.102)  0.11 (±0.01) 0.07 (±0.03) 0.11 (±0.02) 7.79 (±3.19)  747(4) B7  EDE2  4.31 (±1.47)  1.17 (±0.180)  0.10 (±0.01) 0.11 (±0.02) 0.12 (±0.03) 93.19 (±19.15 ) 747 C4 EDE2 102 (±25.6) 11.6 (±2.6) 0. 23 (±0.02) 0.08 (±0.01) 0.11 (±0.01) 0.12 (±0.05 1.85 (±0.44) 4.97 (±0.28) 9.40 (±2.83) 7.47 (±1.65 0.43 (±0.12) 0.73 (±0.20) 1.04 (±0.31) 1.80 (±0.64 The ZIKV sE buffer used for all the crystallization experiments was: 150mM NaCl and 15mM Tris pH 8.
One crystal was used to collect a diffraction dataset for each complex to determine the structure.
" The anisotropy statistics were computed with AIMLESS (REF In parenthesis, the number of carbon alpha atoms used for the calculation; PDB code, Protein Data Bank accession number; au, asymetric unit $ The rmsd is computed using residues 1 to 403 for ZIKV sE or residues 1 to 395 for DENV-2 sE, except when indicated 1,2 . # There are two independent half dimer (ZIKV sE/EDE1 C8 ScFv) in the asymetric unit. The rmsd is computed between the two dimers of sE generated by crystallographic symetry for each sE in the asymetric unit. ## This rmsd is computed between the two independent half dimers of sE in the asymetric unit. 1 The rmsd is computed between the sE dimers excluding stem and TM regions of ZIKV (residues 1 to 403) and DENV-2 (residues 1 to 395). 2 The rmsd is computed between the sE dimers including stem and TM regions of ZIKV and DENV-2 (residues 1 to C terminal). 3 The two rmsd values refer to the superposition of the variable domains of Fab A11 in ZIKV sE/EDE2 A11 Fab on each Fab A11 in DENV-2 sE/EDE2 A11 Fab. 
